Q3 2024 EPS Estimates for AngioDynamics, Inc. Reduced by Zacks Research (NASDAQ:ANGO)
AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) – Zacks Research lowered their Q3 2024 earnings per share (EPS) estimates for AngioDynamics in a research report issued on Wednesday, March 13th. Zacks Research analyst D. Dey now expects that the medical instruments supplier will earn ($0.15) per share for the quarter, down from their previous forecast of […]
More Stories
Gold Prices Surge to Highest Level in Over 3 Months
By Naveen Athrappully Gold prices are trading at their highest level in more than three months on Monday, amid continued...
Treasury, IRS Propose Rules on Trump Account Investments
By Naveen Athrappully The Department of the Treasury and the IRS have issued proposed regulations clarifying which investments may be...
Iryna Zarutska’s Family Sues City of Charlotte Over Fatal Rail Stabbing, Blaming Security Failures
By Owen Evans The family of 23-year-old Ukrainian refugee Iryna Zarutska, who was stabbed to death in North Carolina, has...
IndyCar Race Caps Summer Events for America’s 250th Birthday
By Travis Gillmore WASHINGTON—More than 100,000 spectators lined the streets to witness history as drivers raced by national monuments on...
Zelenskyy Rejects Calls for Wartime Elections in Ukraine
By Tom Gantert Ukrainian President Volodymyr Zelenskyy said holding elections during the war with Russia would “destroy the country,” in...
DOJ Says Diplomat Discipline Board Can’t Overrule Secretary of State
By Matthew Vadum A Department of Justice (DOJ) body held that an independent board that reviews disciplinary actions against U.S....